With more than a quarter of high school students reporting electronic cigarette (e-cigarette) use in the previous month, public health officials are scrambling to address this burgeoning epidemic.1 A recent court order is expected to place the US Food and Drug Administration (FDA), which has been slow to respond to rising e-cigarette use, at the center of the government’s response. Under this order, e-cigarette companies will be required to submit marketing applications to the FDA in September 2020. Unless applicants can demonstrate that use of these products is “appropriate for the protection of the public health,” the FDA will not authorize their continued sale.2
Identify all potential conflicts of interest that might be relevant to your comment.
Conflicts of interest comprise financial interests, activities, and relationships within the past 3 years including but not limited to employment, affiliation, grants or funding, consultancies, honoraria or payment, speaker's bureaus, stock ownership or options, expert testimony, royalties, donation of medical equipment, or patents planned, pending, or issued.
Err on the side of full disclosure.
If you have no conflicts of interest, check "No potential conflicts of interest" in the box below. The information will be posted with your response.
Not all submitted comments are published. Please see our commenting policy for details.
Berman ML, Glasser AM. The Public Health Standard in Action—Analysis of the US Food and Drug Administration’s IQOS Review. JAMA Oncol. 2020;6(12):1864–1865. doi:10.1001/jamaoncol.2020.3316
Coronavirus Resource Center
Customize your JAMA Network experience by selecting one or more topics from the list below.
Create a personal account or sign in to: